Cervical lymph node metastases from unknown primary cancer: A single-institution experience with intensity-modulated radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 5, 2012, Pages 1866-1871

  Villeneuve, Hugo ^a   Després, Philippe ^a   Fortin, Bernard ^a   Filion, Edith ^a   Donath, David ^a   Soulières, Denis ^a   Guertin, Louis ^a   Ayad, Tarek ^a   Christopoulos, Apostolos ^a   Nguyen Tan, Phuc Felix ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Cancer; Head and neck; Intensity modulated radiotherapy; Lymph node metastases; Unknown primary

Indexed keywords

CANCER; HEAD AND NECK; INTENSITY-MODULATED RADIOTHERAPY; LYMPH NODE METASTASIS; UNKNOWN PRIMARY;

BODY FLUIDS; CHEMOTHERAPY; DISEASE CONTROL; DISEASES; DOSIMETRY; PATHOLOGY; RADIOTHERAPY; TOXICITY;

PHYSICAL THERAPY;

CARBOPLATIN; CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER OF UNKNOWN PRIMARY SITE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CERVICAL LYMPH NODE; CLINICAL ARTICLE; CONTINUOUS INFUSION; DERMATITIS; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LYMPH NODE METASTASIS; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NECK DISSECTION; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; SALIVARY GLAND; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR VOLUME; WEIGHT REDUCTION; XEROSTOMIA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC IRRADIATION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK; NEOPLASM STAGING; NEOPLASMS, UNKNOWN PRIMARY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; XEROSTOMIA;

EID: 84858705629     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.02.031     Document Type: Article

References (37)

1. Grau C, Johansen LV, Jakobsen J, et al. Cervical lymph node metastases from unknown primary tumours: Results from a national survey by the Danish Society for Head and Neck Oncology. Radiother Oncol 2000;55:121-129. (Pubitemid 30229986)
2. Friesland S, Lind MG, Lundgren J, et al. Outcome of ipsilateral treatment for patients with metastases to neck nodes of unknown origin. Acta Oncol 2001;40:24-28. (Pubitemid 32234588)
3. Sinnathamby K, Peters LJ, Laidlaw C, et al. The occult head and neck primary: To treat or not to treat? Clin Oncol (R Coll Radiol) 1997;9:322-329. (Pubitemid 27480632)
4. Colletier PJ, Garden AS, Morrison WH, et al. Postoperative radiation for squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site: Outcomes and patterns of failure. Head Neck 1998;20:674-681. (Pubitemid 28462821)
5. Weir L, Keane T, Cummings B, et al. Radiation treatment of cervical lymph node metastases from an unknown primary: An analysis of outcome by treatment volume and other prognostic factors. Radiother Oncol 1995;35:206-211.
6. Reddy SP, Marks JE. Metastatic carcinoma in the cervical lymph nodes from an unknown primary site: Results of bilateral neck plus mucosal irradiation vs. ipsilateral neck irradiation. Int J Radiat Oncol Biol Phys 1997;37: 797-802. (Pubitemid 27181311)
7. Harper CS, Mendenhall WM, Parsons JT, et al. Cancer in neck nodes with unknown primary site: Role of mucosal radiotherapy. Head Neck 1990;12:463-469.
8. Chao KS, Majhail N, Huang CJ, et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: A comparison with conventional techniques. Radiother Oncol 2001;61:275-280. (Pubitemid 33127232)
9. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000;48:7-16. (Pubitemid 30488207)
10. Mendenhall WM, Amdur RJ, Palta JR. Intensity-modulated radiotherapy in the standard management of head and neck cancer: Promises and pitfalls. J Clin Oncol 2006;24:2618-2623. (Pubitemid 46622082)
11. Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group, Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000;355:949-955. (Pubitemid 30148259)
12. Coker DD, Casterline PF, Chambers RG, et al. Metastases to lymph nodes of the head and neck from an unknown primary site. Am J Surg 1977;134:517-522. (Pubitemid 8201798)
13. Coster JR, Foote RL, Olsen KD, et al. Cervical nodal metastasis of squamous cell carcinoma of unknown origin: Indications for withholding radiation therapy. Int J Radiat Oncol Biol Phys 1992;23:743-749.
14. Wang RC, Goepfert H, Barber AE, et al. Unknown primary squamous cell carcinoma metastatic to the neck. Arch Otolaryngol Head Neck Surg 1990;116:1388-1393.
15. Lu X, Hu C, Ji Q, et al. Squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site: The impact of radiotherapy. Tumori 2009;95:185-190.
16. Barrie JR, Knapper WH, StrongEW. Cervical nodal metastases of unknown origin. Am J Surg 1970;120:466-470.
17. Jesse RH, Perez CA, Fletcher GH. Cervical lymph node metastasis: Unknown primary cancer. Cancer 1973;31:854-859.
18. Jereczek-Fossa BA, Jassem J, Orecchia R. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary. Cancer Treat Rev 2004;30:153-164. (Pubitemid 38418053)
19. Nieder C, Ang KK. Cervical lymph node metastases from occult squamous cell carcinoma. Curr Treat Options Oncol 2002; 3:33-40.
20. Franzen L, Funegard U, Ericson T, et al. Parotid gland function during and following radiotherapy of malignancies in the head and neck: A consecutive study of salivary flow and patient discomfort. Eur J Cancer 1992;28:457-462.
21. Makkonen TA, Nordman E. Estimation of long-term salivary gland damage induced by radiotherapy. Acta Oncol 1987;26: 307-312. (Pubitemid 18014605)
22. Jabbari S, Kim HM, Feng M, et al. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: Initial report. Int J Radiat Oncol Biol Phys 2005;63:725-731. (Pubitemid 41400058)
23. Saarilahti K, Kouri M, Collan J, et al. Intensity modulated radiotherapy for head and neck cancer: Evidence for preserved salivary gland function. Radiother Oncol 2005;74:251-258. (Pubitemid 40349134)
24. Braam PM, Terhaard CH, Roesink JM, et al. Intensity-modulated radiotherapy significantly reduces xerostomia compared with conventional radiotherapy. Int J Radiat Oncol Biol Phys 2006;66:975-980. (Pubitemid 44633513)
25. Yao M, Karnell LH, Funk GF, et al. Health-related quality-oflife outcomes following IMRT versus conventional radiotherapy for oropharyngeal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2007;69:1354-1360. (Pubitemid 350116394)
26. Klem ML, Mechalakos JG, Wolden SL, et al. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: Toxicity and preliminary efficacy. Int J Radiat Oncol Biol Phys 2008;70:1100-1107. (Pubitemid 351296099)
27. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091-2098. (Pubitemid 37464533)
28. Denis F, Garaud P, Bardet E, et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 2004;22:69-76. (Pubitemid 41095116)
29. Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998;338: 1798-1804. (Pubitemid 28277960)
30. Wendt TG, Grabenbauer GG, Rodel CM, et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study. J Clin Oncol 1998;16:1318-1324. (Pubitemid 28175746)
31. de Braud F, Heilbrun LK, Ahmed K, et al. Metastatic squamous cell carcinoma of an unknown primary localized to the neck: Advantages of an aggressive treatment. Cancer 1989;64:510-515. (Pubitemid 19180415)
32. Jeremic B, Zivic L, Jevremovic S. Radiotherapy and cisplatin in metastatic squamous cell carcinoma of an unknown primary tumor localized to the neck: A phase II study. J Chemother 1992;4:399-402. (Pubitemid 23030548)
33. Argiris A, Smith SM, Stenson K, et al. Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary. Ann Oncol 2003;14: 1306-1311. (Pubitemid 37039060)
34. Beldi D, Jereczek-Fossa BA, D'Onofrio A, et al. Role of radiotherapy in the treatment of cervical lymph node metastases from an unknown primary site: Retrospective analysis of 113 patients. Int J Radiat Oncol Biol Phys 2007;69:1051-1058. (Pubitemid 47625836)
35. Madani I, Vakaet L, Bonte K, et al. Intensity-modulated radiotherapy for cervical lymph node metastases from unknown primary cancer. Int J Radiat Oncol Biol Phys 2008;71:1158-1166.
36. Frank SJ, Rosenthal DI, Petsuksiri J, et al. Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson Cancer Center outcomes and patterns of failure. Int J Radiat Oncol Biol Phys 2010;78:1005-1010.
37. Eisbruch A, Schwartz M, Rasch C, et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: Which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys 2004;60:1425-1439. (Pubitemid 39601860)